Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report

Full text
Show less -
Gozzi-Silva, Sarah Cristina [1, 2] ; Benard, Gil [2] ; Alberca, Ricardo Wesley [2] ; Yendo, Tatiana Mina [2] ; Emidio Teixeira, Franciane Mouradian [1, 2] ; Oliveira, Luana de Mendonca [2] ; Beserra, Danielle Rosa [2] ; Pietrobon, Anna Julia [1, 2] ; de Oliveira, Emily Araujo [1, 2] ; Calvielli Castelo Branco, Anna Claudia [1, 2] ; de Souza Andrade, Milena Mary [2] ; Fernandes, Iara Grigoletto [2] ; Pereira, Natalli Zanete [2] ; Leuzzi Ramos, Yasmim Alefe [2] ; Lima, Julia Cataldo [2] ; Provenci, Bruna [3] ; Mangini, Sandrigo [3] ; da Silva Duarte, Alberto Jose [2] ; Sato, Maria Notomi [1, 2]
Total Authors: 19
[1] Univ Sao Paulo, Inst Biomed Sci, BR-05508000 Sao Paulo - Brazil
[2] Sch Med Sao Paulo FMUSP, Lab Dermatol & Immunodeficiencies LIM 56, Inst Trop Med, BR-05403000 Sao Paulo - Brazil
[3] Univ Sao Paulo HCFMUSP, Hosp Clin, Inst Coracao Incor, Sch Med, BR-05403900 Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Web of Science Citations: 0

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients. (AU)

FAPESP's process: 18/18230-6 - Evaluation of the efficacy of the Zika Virus chimeric DNA vaccine and the lysosomal-associated membrane protein in mice
Grantee:Franciane Mouradian Emidio Teixeira
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 17/18199-9 - Effect of maternal supplementation with retinoic acid during breastfeeding on the immune response of mice offspring
Grantee:Maria Notomi Sato
Support Opportunities: Regular Research Grants
FAPESP's process: 19/02679-7 - Effect of maternal and paternal supplementation with antioxidant in pulmonary inflammatory process of the offspring of mice
Grantee:Ricardo Wesley Alberca Custódio
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 19/26928-6 - Phenotypic and functional evaluation of Regulatory T cells in gestational obesity
Grantee:Emily Araujo de Oliveira
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 19/22448-0 - Analysis of natural killer memory cells and the antiviral response of CD8 + T cells in SARS-CoV-2 infection
Grantee:Sarah Cristina Gozzi e Silva
Support Opportunities: Scholarships in Brazil - Master